Pharmacotherapy for chronic hemorrhagic radiation proctitis

Endoscopic thermal therapy and formalin are being increasingly recommended for the treatment of chronic hemorrhagic radiation proctitis. It may be too early, however, to discard pharmacologic agents from the management process, especially in medical institutions where specialized equipment is unavai...

Full description

Bibliographic Details
Main Authors: Alif Gul, Yunus Gul, Prasannan, Subhita, Jabar, Mohd Faisal, Shaker, Abdul Rahman Hikmet, Moissinac, Kevin
Format: Article
Language:English
Published: Springer 2002
Online Access:http://psasir.upm.edu.my/id/eprint/36247/
http://psasir.upm.edu.my/id/eprint/36247/1/Pharmacotherapy%20for%20chronic%20hemorrhagic%20radiation%20proctitis.pdf
_version_ 1848848278970433536
author Alif Gul, Yunus Gul
Prasannan, Subhita
Jabar, Mohd Faisal
Shaker, Abdul Rahman Hikmet
Moissinac, Kevin
author_facet Alif Gul, Yunus Gul
Prasannan, Subhita
Jabar, Mohd Faisal
Shaker, Abdul Rahman Hikmet
Moissinac, Kevin
author_sort Alif Gul, Yunus Gul
building UPM Institutional Repository
collection Online Access
description Endoscopic thermal therapy and formalin are being increasingly recommended for the treatment of chronic hemorrhagic radiation proctitis. It may be too early, however, to discard pharmacologic agents from the management process, especially in medical institutions where specialized equipment is unavailable. We prospectively assessed the effectiveness of medical therapy in 14 consecutive patients with chronic hemorrhagic radiation proctitis from July 1999 to June 2001. All 14 subjects were women (mean age 56 years), 13 of whom had had radio-therapy for Cancer of the cervix. The median time to onset of Symptoms following irradiation was 16 months. Six patients had a hemoglobin level of<8 g/dl, and blood transfusion was required in 11 patients. In five patients (36%) initially treated with hydrocortisone enemas prior to referral, this treatment continued; and the remaining nine patients were commenced on sucralfate enemas. Two patients given rectal hydrocortisone continued to bleed and were treated with sucralfate enemas and topical formalin, respectively. Rectal sucralfate Suspension effectively procured symptomatic alleviation in all 11 patients. Rectal bleeding recurred in two patients who had been managed exclusively with hydrocortisone and sucralfate enemas, respectively, over a mean follow-up of 6 months. Both patients were managed with topical formalin, which con-trolled their Symptoms. Even though the number of subjects in this study is small, sucralfate enema can be recommended as an effective first-line agent for managing patients with chronic hemorrhagic radiation proctitis. The use of more specialized therapy can therefore be reserved for cases where primary treatment failure occurs with sucralfate therapy.
first_indexed 2025-11-15T09:31:58Z
format Article
id upm-36247
institution Universiti Putra Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T09:31:58Z
publishDate 2002
publisher Springer
recordtype eprints
repository_type Digital Repository
spelling upm-362472016-04-07T07:08:05Z http://psasir.upm.edu.my/id/eprint/36247/ Pharmacotherapy for chronic hemorrhagic radiation proctitis Alif Gul, Yunus Gul Prasannan, Subhita Jabar, Mohd Faisal Shaker, Abdul Rahman Hikmet Moissinac, Kevin Endoscopic thermal therapy and formalin are being increasingly recommended for the treatment of chronic hemorrhagic radiation proctitis. It may be too early, however, to discard pharmacologic agents from the management process, especially in medical institutions where specialized equipment is unavailable. We prospectively assessed the effectiveness of medical therapy in 14 consecutive patients with chronic hemorrhagic radiation proctitis from July 1999 to June 2001. All 14 subjects were women (mean age 56 years), 13 of whom had had radio-therapy for Cancer of the cervix. The median time to onset of Symptoms following irradiation was 16 months. Six patients had a hemoglobin level of<8 g/dl, and blood transfusion was required in 11 patients. In five patients (36%) initially treated with hydrocortisone enemas prior to referral, this treatment continued; and the remaining nine patients were commenced on sucralfate enemas. Two patients given rectal hydrocortisone continued to bleed and were treated with sucralfate enemas and topical formalin, respectively. Rectal sucralfate Suspension effectively procured symptomatic alleviation in all 11 patients. Rectal bleeding recurred in two patients who had been managed exclusively with hydrocortisone and sucralfate enemas, respectively, over a mean follow-up of 6 months. Both patients were managed with topical formalin, which con-trolled their Symptoms. Even though the number of subjects in this study is small, sucralfate enema can be recommended as an effective first-line agent for managing patients with chronic hemorrhagic radiation proctitis. The use of more specialized therapy can therefore be reserved for cases where primary treatment failure occurs with sucralfate therapy. Springer 2002 Article PeerReviewed application/pdf en http://psasir.upm.edu.my/id/eprint/36247/1/Pharmacotherapy%20for%20chronic%20hemorrhagic%20radiation%20proctitis.pdf Alif Gul, Yunus Gul and Prasannan, Subhita and Jabar, Mohd Faisal and Shaker, Abdul Rahman Hikmet and Moissinac, Kevin (2002) Pharmacotherapy for chronic hemorrhagic radiation proctitis. World Journal of Surgery, 26 (12). pp. 1499-1502. ISSN 0364-2313; ESSN: 1432-2323 http://link.springer.com/article/10.1007%2Fs00268-002-6529-8 10.1007/s00268-002-6529-8
spellingShingle Alif Gul, Yunus Gul
Prasannan, Subhita
Jabar, Mohd Faisal
Shaker, Abdul Rahman Hikmet
Moissinac, Kevin
Pharmacotherapy for chronic hemorrhagic radiation proctitis
title Pharmacotherapy for chronic hemorrhagic radiation proctitis
title_full Pharmacotherapy for chronic hemorrhagic radiation proctitis
title_fullStr Pharmacotherapy for chronic hemorrhagic radiation proctitis
title_full_unstemmed Pharmacotherapy for chronic hemorrhagic radiation proctitis
title_short Pharmacotherapy for chronic hemorrhagic radiation proctitis
title_sort pharmacotherapy for chronic hemorrhagic radiation proctitis
url http://psasir.upm.edu.my/id/eprint/36247/
http://psasir.upm.edu.my/id/eprint/36247/
http://psasir.upm.edu.my/id/eprint/36247/
http://psasir.upm.edu.my/id/eprint/36247/1/Pharmacotherapy%20for%20chronic%20hemorrhagic%20radiation%20proctitis.pdf